Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data

被引：0
|
作者：
Tarhini, Ahmad A.
Tan, Aik Choon
Xie, Mengyu
El Naqa, Issam
Saghand, Payman Ghasemi
Dai, Donghai
Chen, James Lin
Ratan, Aakrosh
McCarter, Martin
Carpten, John D.
Colman, Howard
Ikeguchi, Alexandra
Tripathi, Abhishek
Puzanov, Igor
Arnold, Susanne M.
Churchman, Michelle L.
Hwu, Patrick
Conejo-Garcia, Jose
Dalton, William S.
Weiner, George J.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, l, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA USA
[4] Ohio State Univ, Columbus, OH USA
[5] Univ Virginia, Charlottesville, VA USA
[6] Univ Colorado, Comprehens Canc Ctr, Aurora, CO USA
[7] Univ Southern Calif, Los Angeles, CA USA
[8] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[9] Univ Oklahoma, Oklahoma City, OK USA
[10] Univ Oklahoma, Stephenson Canc Ctr, Hlth Sci Ctr, Oklahoma City, OK USA
[11] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[12] Univ Kentucky, Lexington, KY USA
[13] M2Gen, Tampa, FL USA
[14] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2618
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Mantle, Luke
    Fournier, Cynthia
    Butler, Marcus O.
    Spreafico, Anna
    Saibil, Samuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] A Real-World Comparison of the Safety Profile for Immune Checkpoint Inhibitors in Oncology Patients
    Alwhaibi, Abdulrahman
    Alenazi, Miteb A.
    Alghadeer, Sultan
    Mansy, Wael
    Alsaif, Reem A.
    Abualreesh, Nawaf E.
    Alanazi, Rakan J.
    Alroumi, Abdullah
    Alanazi, Saleh A.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [33] Clinical characteristics and prognosis of liver injury induced by immune checkpoint inhibitors in patients with malignancies: A real-world retrospective study
    Jiang, Ying
    Lv, Minzhi
    Jin, Zhiping
    Wu, Yi
    Li, Xiaoyu
    Zhang, Ningping
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (11) : 2870 - 2882
  • [34] COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma
    Arenbergerova, M.
    Gkalpakiotis, S.
    Arenberger, P.
    Fialova, A.
    Pasek, M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1782 - 1783
  • [35] The association between body mass index and immune checkpoint inhibitors outcomes in melanoma: Results from real-world data
    Elantably, Dina
    Wang, Jiasheng
    Al Armashi, Abdul Rahman
    Al Zubaidi, Anas
    Alkrekshi, Akram
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors
    Sonke, Eric
    Angeles, Arkhjamil
    Nguyen, Thao Phuong
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
    van Not, Olivier J.
    Wind, Thijs T.
    Ismail, Rawa K.
    Bhattacharya, Arkajyoti
    Jalving, Mathilde
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Boers-Sonderen, Marye J.
    van den Eertwegh, Alfonsus J. M.
    de Groot, Jan Willem B.
    Haanen, John B.
    Kapiteijn, Ellen
    Bloem, Manja
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Stevense-den Boer, Marion
    van der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Blokx, Willeke A. M.
    Suijkerbuijk, Karijn P. M.
    Fehrmann, Rudolf S. N.
    Hospers, Geke A. P.
    CANCERS, 2023, 15 (11)
  • [38] Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors
    Ariyasu, Ryo
    Kakuto, Sho
    Miyadera, Keiki
    Akita, Takahiro
    Kiritani, Ayu
    Tsugitomi, Ryosuke
    Amino, Yoshiaki
    Uchibori, Ken
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (06):
  • [39] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Glenn J. Hanna
    Emily S. Ruiz
    Nicole R. LeBoeuf
    Manisha Thakuria
    Chrysalyne D. Schmults
    James A. Decaprio
    Ann W. Silk
    British Journal of Cancer, 2020, 123 : 1535 - 1542
  • [40] Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
    McLean, Luke S.
    Lim, Annette M.
    Bressel, Mathias
    Thai, Alesha A.
    Rischin, Danny
    DRUGS & AGING, 2024, 41 (03) : 271 - 281
12345